Reduction of Calponin h1 expression in human colon cancer blood vessels

European Journal of Surgical Oncology

Volumn 34, Issue 5, 2008, Pages 531-537

  Yanagisawa, Y ^a,b   Takeoka, M ^a   Ehara, T ^b   Itano, N ^a   Miyagawa, S ^b   Taniguchi, S ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calponin h1; Colon cancer; Down regulation; Tumor vessels

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; CALPONIN H1; FORMALDEHYDE; PARAFFIN; PEROXIDASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; COLON CANCER; COLON RESECTION; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PERICYTE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TISSUE SECTION; TUMOR VASCULARIZATION;

AGED; AGED, 80 AND OVER; BLOOD VESSELS; CALCIUM-BINDING PROTEINS; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICROFILAMENT PROTEINS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 41949136231     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.05.010     Document Type: Article

References (30)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 (1995) 27-31
2. Pluda J.M. Tumor-associated anigiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin Oncol 24 (1997) 203-221
3. Eberhard A., Kahlert S., Goede V., Hemmerlein B., Plate K.H., and Augustin H.G. Heterogeneity of Angiogenesis and blood vessel maturation in human tumors: implication for antiangiogenic tumor therapies. Cancer Res 60 (2000) 1388-1393
4. Yonenaga Y., Mori A., Onodera H., et al. Absent of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology 69 (2005) 159-166
5. Kake T., Kimura S., Takahashi K., and Maruyama K. Calponin induces actin polymerization at low ionic strength and inhibits depolymerization of actin filaments. Biochem J 312 (1995) 587-592
6. Hayashi K., Saga H., Chimori Y., Kimura K., Yamanaka Y., and Sobue K. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J Biol Chem 273 (1998) 28860-28867
7. Taniguchi S., Takeoka M., Ehara T., et al. Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells. Cancer Res 61 (2001) 7627-7634
8. Hashimoto S., Takeoka M., and Taniguchi S. Suppression of peritoneal dissemination through protecting mesothelial cells from retraction by cancer cells. Int J Cancer 107 (2003) 557-563
9. Taniguchi S. Suppression of cancer phenotypes through a multifunctional actin-binding protein, calponin, that attacks cancer cells and simultaneously protects the host from invasion. Cancer Sci 96 (2006) 738-746
10. Koganehira Y., Takeoka M., Ehara T., et al. Reduced expression of actin-binding proteins, h-caldesmon and calponin h1, in the vascular smooth muscle inside melanoma lesions: an adverse prognostic factor for malignant melanoma. Br J Dermatol 148 (2003) 971-980
11. Sasaki Y., Yamamura H., Kawakami Y., et al. Expression of smooth muscle calponin in tumor vessels of human hepatocellular carcinoma and its possible association with prognosis. Cancer 94 (2002) 1777-1786
12. Islam A.H., Ehara T., Kato H., et al. Calponin h1 expression in renal tumor vessels: correlations with multiple pathological factors of renal cell carcinoma. J Urol 171 (2004) 1319-1323
13. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
14. Okamoto-Inoue M., Nakayama J., Hori Y., and Taniguchi S. Human malignant melanoma cells release a factor than inhibits the expression of smooth muscle alpha-actin. J Dermatol Sci 23 (2000) 170-177
15. Kobayashi H., Tsuruchi N., Sugihara K., et al. Expression of alpha-smooth muscle actin in benign or malignant ovarian tumors. Gynecol Oncol 48 (1993) 308-313
16. Kerbel R., and Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2 (2002) 727-739
17. Liang J.T., Huang K.C., Jeng Y.M., Lee P.H., Lai H.S., and Hsu H.C. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer. Br J Surg 91 (2004) 355-361
18. Takahashi Y., Kitadai Y., Bucana C.D., Cleary K.R., and Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55 (1995) 3964-3968
19. Armulik A., Abramsson A., and Betsholtz C. Endothelial/pericyte interactions. Circ Res 97 (2005) 512-523
20. Caok R., Björndahl M.A., Religa P., et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6 (2004) 333-345
21. Hirschi K.K., and Rohovsky S.A. D'Amore PA. PDGF, TGF-R, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141 (1998) 805-814
22. Nishishita T., and Lin P.C. Angiopoietin 1, PDGF-B, and TGF-β gene regulation in endothelial cell and smooth muscle cell interaction. J Cell Biochem 91 (2004) 584-593
23. Horiuchi A., Nikaido T., Taniguchi S., and Fujii S. Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma. J Natl Cancer Inst 91 (1999) 790-796
24. Takeoka M., Ehara T., Sagara J., Hashimoto S., and Taniguchi S. Calponin h1 induced a flattened morphology and suppressed the growth of human fibrosarcoma HT1080 cells. Eur J Cancer 38 (2002) 436-442
25. Kaneko M., Takeoka M., Oguchi M., et al. Calponin h1 suppresses tumor growth of src-induced transformed 3Y1 cells in association with a decrease in angiogenesis. Jpn J Cancer Res 93 (2002) 935-943
26. Lener T., Burgstaller G., and Gimona M. The role of calponin in the gene profile of metastatic cells: inhibition of metastatic cell motility by multiple calponin repeats. FEBBS Lett 556 (2004) 221-226
27. Ebisuya M., Kondoh K., and Nishida E. The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J Cell Sci 118 (2005) 2997-3002
28. Cristi E., Perrone G., Toscano G., et al. Tumour proliferation, angiogenesis, and ploidy status in human colon cancer. J Clin Pathol 58 (2005) 1170-1174
29. Galizia G., Lieto E., Ferraraccio F., et al. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 10 (2004) 3490-3499
30. Cascinu S., Staccioli M.P., Gasparini G., et al. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res 6 (2000) 2803-2807